$CMRX
CHIMERIX INC Stock $cmrx

$cmrx Overview Financials Valuation SEC Filings Company Website

2017 Q2 Form 10-Q Financial Statement

#000111748017000017 Filed on May 09, 2017

Income Statement

Concept	2017 Q2	2017 Q1	2016 Q1
Revenue	$675.0K	$1.078M	$1.228M
YoY Change	-63.34%	-12.21%	-0.81%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$6.280M	$6.600M	$6.920M
YoY Change	-4.99%	-4.62%	13.02%
% of Gross Profit
Research & Development	$11.64M	$12.74M	$20.94M
YoY Change	-15.43%	-39.14%	20.02%
% of Gross Profit
Depreciation & Amortization	$280.0K	$281.0K	$267.0K
YoY Change	7.69%	5.24%	134.21%
% of Gross Profit
Operating Expenses	$17.92M	$19.34M	$27.86M
YoY Change	-12.01%	-30.59%	18.22%
Operating Profit	-$17.25M	-$18.26M	-$26.63M
YoY Change	-6.91%	-31.44%	19.27%
Interest Expense	$570.0K	$510.0K	$370.0K
YoY Change	50.0%	37.84%	516.67%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$16.68M	-$17.75M	-$26.26M
YoY Change	-8.1%	-32.41%	17.92%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$16.68M	-$17.75M	-$26.26M
YoY Change	-8.09%	-32.39%	17.94%
Net Earnings / Revenue	-2471.11%	-1646.94%	-2138.44%
Basic Earnings Per Share
Diluted Earnings Per Share	-$356.0K	-$381.1K	-$568.6K
COMMON SHARES
Basic Shares Outstanding	46.65M shares	46.56M shares	46.18M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2017 Q2	2017 Q1	2016 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$148.5M	$161.7M	$263.3M
YoY Change	-45.56%	-38.59%	50.89%
Cash & Equivalents	$23.89M	$21.87M	$27.50M
Short-Term Investments	$124.6M	$139.8M	$235.8M
Other Short-Term Assets	$3.100M	$2.400M	$4.900M
YoY Change	-35.42%	-51.02%	172.22%
Inventory
Prepaid Expenses
Receivables	$0.00	$811.0K	$566.0K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$151.7M	$164.9M	$268.8M
YoY Change	-45.42%	-38.66%	51.64%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.306M	$2.567M	$3.006M
YoY Change	-23.64%	-14.6%	126.19%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$103.6M	$104.9M	$52.40M
YoY Change	247.65%	100.19%	-44.96%
Other Assets	$51.00K	$59.00K	$64.00K
YoY Change	-45.16%	-7.81%	-78.45%
Total Long-Term Assets	$106.0M	$107.5M	$55.43M
YoY Change	222.04%	93.95%	-42.77%
TOTAL ASSETS
Total Short-Term Assets	$151.7M	$164.9M	$268.8M
Total Long-Term Assets	$106.0M	$107.5M	$55.43M
Total Assets	$257.7M	$272.4M	$324.2M
YoY Change	-17.09%	-15.99%	18.28%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.609M	$2.813M	$3.568M
YoY Change	-61.84%	-21.16%	-48.44%
Accrued Expenses	$6.159M	$5.819M	$6.638M
YoY Change	-2.41%	-12.34%	0.12%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$7.768M	$8.632M	$10.21M
YoY Change	-26.22%	-15.42%	-37.93%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Other Long-Term Liabilities	$200.0K	$400.0K	$300.0K
YoY Change	-33.33%	33.33%	86.34%
Total Long-Term Liabilities	$200.0K	$400.0K	$300.0K
YoY Change	-33.33%	33.33%	86.34%
TOTAL LIABILITIES
Total Short-Term Liabilities	$7.768M	$8.632M	$10.21M
Total Long-Term Liabilities	$200.0K	$400.0K	$300.0K
Total Liabilities	$8.014M	$9.033M	$10.54M
YoY Change	-26.03%	-14.27%	-36.54%
SHAREHOLDERS EQUITY
Retained Earnings	-$450.2M	-$433.6M	-$365.7M
YoY Change	17.3%	18.56%	49.68%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$249.7M	$263.4M	$313.7M
YoY Change
Total Liabilities & Shareholders Equity	$257.7M	$272.4M	$324.2M
YoY Change	-17.09%	-15.99%	18.28%

Cashflow Statement

Concept	2017 Q2	2017 Q1	2016 Q1
OPERATING ACTIVITIES
Net Income	-$16.68M	-$17.75M	-$26.26M
YoY Change	-8.09%	-32.39%	17.94%
Depreciation, Depletion And Amortization	$280.0K	$281.0K	$267.0K
YoY Change	7.69%	5.24%	134.21%
Cash From Operating Activities	-$13.01M	-$13.62M	-$28.64M
YoY Change	3.67%	-52.43%	52.0%
INVESTING ACTIVITIES
Capital Expenditures	-$10.00K	$5.000K	$232.0K
YoY Change	-96.3%	-97.84%	74.44%
Acquisitions
YoY Change
Other Investing Activities	$14.94M	-$16.36M	$35.60M
YoY Change	-13.94%	-145.96%	-165.21%
Cash From Investing Activities	$14.93M	-$16.37M	$35.37M
YoY Change	-12.64%	-146.28%	-164.63%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	100.0K	$395.0K	$166.0K
YoY Change	400.0%	137.95%	-76.32%
NET CHANGE
Cash From Operating Activities	-13.01M	-$13.62M	-$28.64M
Cash From Investing Activities	14.93M	-$16.37M	$35.37M
Cash From Financing Activities	100.0K	$395.0K	$166.0K
Net Change In Cash	2.020M	-$29.60M	$6.898M
YoY Change	-55.7%	-529.07%	-109.47%
FREE CASH FLOW
Cash From Operating Activities	-$13.01M	-$13.62M	-$28.64M
Capital Expenditures	-$10.00K	$5.000K	$232.0K
Free Cash Flow	-$13.00M	-$13.63M	-$28.87M
YoY Change	5.86%	-52.79%	52.16%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2016Q4	cmrx	Accrued Development Liabilities AccruedDevelopmentLiabilities	2257000	USD
CY2017Q1	cmrx	Accrued Development Liabilities AccruedDevelopmentLiabilities	2658000	USD
CY2017Q1	cmrx	Availableforsale Securities Debt Maturities Year Two Fair Value AvailableforsaleSecuritiesDebtMaturitiesYearTwoFairValue	104884000	USD
CY2017Q1	dei	Amendment Flag AmendmentFlag	false
CY2017Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2017Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2017Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
CY2017Q1	dei	Document Period End Date DocumentPeriodEndDate	2017-03-31
CY2017Q1	dei	Document Type DocumentType	10-Q
CY2017Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001117480
CY2017Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	46651793	shares
CY2017Q1	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2017Q1	dei	Entity Registrant Name EntityRegistrantName	CHIMERIX INC
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3890000	USD
CY2017Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	2813000	USD
CY2016Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1599000	USD
CY2017Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	811000	USD
CY2016Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-397000	USD
CY2017Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-72000	USD
CY2016Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	6215000	USD
CY2017Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5819000	USD
CY2016Q4	us-gaap	Accrued Salaries Current And Noncurrent AccruedSalariesCurrentAndNoncurrent	2906000	USD
CY2017Q1	us-gaap	Accrued Salaries Current And Noncurrent AccruedSalariesCurrentAndNoncurrent	1724000	USD
CY2016Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-440000	USD
CY2017Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-109000	USD
CY2016Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	692422000	USD
CY2017Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	696995000	USD
CY2016Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3915000	USD
CY2017Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4028000	USD
CY2016Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	300000	shares
CY2017Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1800000	shares
CY2016Q4	us-gaap	Assets Assets	286770000	USD
CY2017Q1	us-gaap	Assets Assets	272407000	USD
CY2016Q4	us-gaap	Assets Current AssetsCurrent	236465000	USD
CY2017Q1	us-gaap	Assets Current AssetsCurrent	164897000	USD
CY2016Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	227965000	USD
CY2017Q1	us-gaap	Available For Sale Securities AvailableForSaleSecurities	244713000	USD
CY2016Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	20000	USD
CY2017Q1	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	355000	USD
CY2016Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	460000	USD
CY2017Q1	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	337000	USD
CY2016Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	228405000	USD
CY2017Q1	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	244695000	USD
CY2016Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	0	USD
CY2017Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	0	USD
CY2016Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss	460000	USD
CY2017Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss	337000	USD
CY2016Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue	129490000	USD
CY2017Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue	232011000	USD
CY2016Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	460000	USD
CY2017Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	337000	USD
CY2016Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	129490000	USD
CY2017Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	232011000	USD
CY2016Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	0	USD
CY2017Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	0	USD
CY2016Q4	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	180558000	USD
CY2017Q1	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	139829000	USD
CY2017Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	137933000	USD
CY2017Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	242817000	USD
CY2016Q4	us-gaap	Available For Sale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Less Than One Year AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsLessThanOneYear	24	security
CY2017Q1	us-gaap	Available For Sale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Less Than One Year AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsLessThanOneYear	51	security
CY2016Q4	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	47407000	USD
CY2017Q1	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	104884000	USD
CY2016Q4	us-gaap	Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions1 AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1	24	security
CY2017Q1	us-gaap	Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions1 AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1	51	security
CY2016Q4	us-gaap	Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Greater Than Or Equal To One Year AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsGreaterThanOrEqualToOneYear	0	security
CY2017Q1	us-gaap	Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Greater Than Or Equal To One Year AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsGreaterThanOrEqualToOneYear	0	security
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	20605000	USD
CY2016Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	27503000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	51463000	USD
CY2017Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	21866000	USD
CY2016Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	6898000	USD
CY2017Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-29597000	USD
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2017Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2017Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	46522475	shares
CY2017Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	46651793	shares
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	46522475	shares
CY2017Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	46651793	shares
CY2016Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	46000	USD
CY2017Q1	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	47000	USD
CY2016Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-25839000	USD
CY2017Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-17423000	USD
CY2016Q1	us-gaap	Contracts Revenue ContractsRevenue	1228000	USD
CY2017Q1	us-gaap	Contracts Revenue ContractsRevenue	1078000	USD
CY2016Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	441000	USD
CY2017Q1	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	401000	USD
CY2016Q1	us-gaap	Depreciation Depreciation	267000	USD
CY2017Q1	us-gaap	Depreciation Depreciation	281000	USD
CY2016Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.57
CY2017Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.38
CY2016Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6924000	USD
CY2017Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6596000	USD
CY2016Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2017Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2016Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-9985000	USD
CY2017Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1440000	USD
CY2016Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1879000	USD
CY2017Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-787000	USD
CY2016Q1	us-gaap	Increase Decrease In Deferred Liabilities IncreaseDecreaseInDeferredLiabilities	-12000	USD
CY2017Q1	us-gaap	Increase Decrease In Deferred Liabilities IncreaseDecreaseInDeferredLiabilities	-47000	USD
CY2016Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1164000	USD
CY2017Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-450000	USD
CY2016Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	372000	USD
CY2017Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	506000	USD
CY2016Q4	us-gaap	Liabilities Liabilities	10546000	USD
CY2017Q1	us-gaap	Liabilities Liabilities	9033000	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	286770000	USD
CY2017Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	272407000	USD
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	10105000	USD
CY2017Q1	us-gaap	Liabilities Current LiabilitiesCurrent	8632000	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	166000	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	395000	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	35367000	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-16369000	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-28635000	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-13623000	USD
CY2016Q1	us-gaap	Net Income Loss NetIncomeLoss	-26260000	USD
CY2017Q1	us-gaap	Net Income Loss NetIncomeLoss	-17754000	USD
CY2016Q1	us-gaap	Operating Expenses OperatingExpenses	27860000	USD
CY2017Q1	us-gaap	Operating Expenses OperatingExpenses	19338000	USD
CY2016Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-26632000	USD
CY2017Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-18260000	USD
CY2016Q1	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	200000	USD
CY2017Q1	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	200000	USD
CY2016Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1052000	USD
CY2017Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1437000	USD
CY2016Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	55000	USD
CY2017Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	59000	USD
CY2016Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	421000	USD
CY2017Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	331000	USD
CY2016Q1	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	0	USD
CY2017Q1	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	0	USD
CY2016Q1	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments	0	USD
CY2017Q1	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments	87509000	USD
CY2016Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	232000	USD
CY2017Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5000	USD
CY2016Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2017Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2016Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2017Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2017Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2017Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2016Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016Q4	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	0	USD
CY2017Q1	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	0	USD
CY2016Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2845000	USD
CY2017Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2391000	USD
CY2016Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	33000	USD
CY2017Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	386000	USD
CY2016Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	35599000	USD
CY2017Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	71145000	USD
CY2016Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	133000	USD
CY2017Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	9000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2843000	USD
CY2017Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2567000	USD
CY2016Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	20936000	USD
CY2017Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	12742000	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-415804000	USD
CY2017Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-433559000	USD
CY2016Q1	us-gaap	Share Based Compensation ShareBasedCompensation	3915000	USD
CY2017Q1	us-gaap	Share Based Compensation ShareBasedCompensation	4028000	USD
CY2017Q1	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	0	shares
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	276224000	USD
CY2017Q1	us-gaap	Stockholders Equity StockholdersEquity	263374000	USD
CY2017Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2016Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	46184134	shares
CY2017Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	46573394	shares

Files In Submission

Name	View Source	Status
0001117480-17-000017-index-headers.html	Edgar Link	pending
0001117480-17-000017-index.html	Edgar Link	pending
0001117480-17-000017.txt	Edgar Link	pending
0001117480-17-000017-xbrl.zip	Edgar Link	pending
a20170331cmrx10-qdocument.htm	Edgar Link	pending
a20170331cmrxex-102.htm	Edgar Link	pending
a20170331cmrxex-103.htm	Edgar Link	pending
a20170331cmrxex-311.htm	Edgar Link	pending
a20170331cmrxex-312.htm	Edgar Link	pending
a20170331cmrxex-321.htm	Edgar Link	pending
a20170331cmrxex-322.htm	Edgar Link	pending
cmrx-20170331.xml	Edgar Link	completed
cmrx-20170331.xsd	Edgar Link	pending
cmrx-20170331_cal.xml	Edgar Link	unprocessable
cmrx-20170331_def.xml	Edgar Link	unprocessable
cmrx-20170331_lab.xml	Edgar Link	unprocessable
cmrx-20170331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CMRX
CHIMERIX INC Stock $cmrx

2017 Q2 Form 10-Q Financial Statement

#000111748017000017 Filed on May 09, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CMRX CHIMERIX INC Stock $cmrx

2017 Q2 Form 10-Q Financial Statement

#000111748017000017 Filed on May 09, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CMRX
CHIMERIX INC Stock $cmrx